[go: up one dir, main page]

WO2009057975A3 - Pharmaceutical composition for the prevention and treatment of cell proliferative diseases comprising of the feathers of birds as the active ingredient - Google Patents

Pharmaceutical composition for the prevention and treatment of cell proliferative diseases comprising of the feathers of birds as the active ingredient Download PDF

Info

Publication number
WO2009057975A3
WO2009057975A3 PCT/KR2008/006446 KR2008006446W WO2009057975A3 WO 2009057975 A3 WO2009057975 A3 WO 2009057975A3 KR 2008006446 W KR2008006446 W KR 2008006446W WO 2009057975 A3 WO2009057975 A3 WO 2009057975A3
Authority
WO
WIPO (PCT)
Prior art keywords
cell proliferative
proliferative diseases
feathers
birds
active ingredient
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/KR2008/006446
Other languages
French (fr)
Other versions
WO2009057975A2 (en
Inventor
Sang Moon Lee
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of WO2009057975A2 publication Critical patent/WO2009057975A2/en
Publication of WO2009057975A3 publication Critical patent/WO2009057975A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/36—Skin; Hair; Nails; Sebaceous glands; Cerumen; Epidermis; Epithelial cells; Keratinocytes; Langerhans cells; Ectodermal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4875—Compounds of unknown constitution, e.g. material from plants or animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Cell Biology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Botany (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

The present invention relates to a pharmaceutical composition for preventing and treating cell proliferative diseases comprising feathers of birds as an active ingredient. More particularly, the present invention relates to a pharmaceutical composition for preventing and treating cell proliferative diseases comprising whole feathers of birds, a powder of a calamus or a rachis of bird feathers, as an active ingredient. A composition for preventing and treating cell proliferative diseases of the present invention has the activity of inhibiting and preventing proliferation of tumor cells. The inventive compositions may be used for preventing and treating cell proliferative diseases, and particularly, used for anticancer purpose such as prevention, reduction, and treatment (or control) of cancer.
PCT/KR2008/006446 2007-11-02 2008-10-31 Pharmaceutical composition for the prevention and treatment of cell proliferative diseases comprising of the feathers of birds as the active ingredient Ceased WO2009057975A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020070111308A KR100989249B1 (en) 2007-11-02 2007-11-02 Pharmaceutical composition for the prevention and treatment of cell proliferative diseases that can inhibit and prevent cell proliferation containing bird feather as an active ingredient
KR10-2007-0111308 2007-11-02

Publications (2)

Publication Number Publication Date
WO2009057975A2 WO2009057975A2 (en) 2009-05-07
WO2009057975A3 true WO2009057975A3 (en) 2009-06-25

Family

ID=40591669

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2008/006446 Ceased WO2009057975A2 (en) 2007-11-02 2008-10-31 Pharmaceutical composition for the prevention and treatment of cell proliferative diseases comprising of the feathers of birds as the active ingredient

Country Status (2)

Country Link
KR (1) KR100989249B1 (en)
WO (1) WO2009057975A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20140093581A1 (en) * 2011-05-02 2014-04-03 Cocky Smart Pty Ltd Avian-Based Treatment for Microbial Infections
WO2012149601A1 (en) * 2011-05-02 2012-11-08 Cocky Smart Pty Ltd Avian-based treatment

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0515761A (en) * 1991-07-10 1993-01-26 Aroma Kagaku Kikai Kogyo:Kk Animal protein foaming agent and its production
JPH11139985A (en) * 1997-11-04 1999-05-25 Ichimaru Pharcos Co Ltd Physiologically active composition derived from hydrolyzate of keratinous protein
WO2004052197A1 (en) * 2002-12-12 2004-06-24 Sang Moon Lee Solid bio-material for a sensor that detects bio-electric signals through the use of the characteristics and functions of bio-epidermal tissues and epidermal tissues of living organisms and the methods for producing the same
KR20050122083A (en) * 2004-06-23 2005-12-28 오상형 Capsule health food containing powdered deer antler and its production process

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0515761A (en) * 1991-07-10 1993-01-26 Aroma Kagaku Kikai Kogyo:Kk Animal protein foaming agent and its production
JPH11139985A (en) * 1997-11-04 1999-05-25 Ichimaru Pharcos Co Ltd Physiologically active composition derived from hydrolyzate of keratinous protein
WO2004052197A1 (en) * 2002-12-12 2004-06-24 Sang Moon Lee Solid bio-material for a sensor that detects bio-electric signals through the use of the characteristics and functions of bio-epidermal tissues and epidermal tissues of living organisms and the methods for producing the same
KR20050122083A (en) * 2004-06-23 2005-12-28 오상형 Capsule health food containing powdered deer antler and its production process

Also Published As

Publication number Publication date
KR20090045478A (en) 2009-05-08
KR100989249B1 (en) 2010-10-20
WO2009057975A2 (en) 2009-05-07

Similar Documents

Publication Publication Date Title
WO2011056021A3 (en) Use of benzo-heterocycle derivatives for preventing and treating cancer or for inhibiting cancer metastasis
WO2016137235A3 (en) Pharmaceutical composition for treating cancer comprising microrna as active ingredient
MX2022007155A (en) Novel chroman derivatives having estrogen receptor degradation activity and uses thereof.
WO2008097640A3 (en) Triazole compounds that are useful in the treatment of proliferative disorders, such as cancer
MY175979A (en) Certain chemical entities, compositions and methods
MX2010002780A (en) Abuse resistant drug formulation.
WO2012064973A3 (en) Heterocyclic compounds and uses thereof
WO2012024620A3 (en) Autotaxin inhibitors and uses thereof
MX2009009537A (en) Nanoparticle comprising rapamycin and albumin as anticancer agent.
UA116211C2 (en) Synergistic compositions for the protection of agrarian crops and the use thereof
MY168791A (en) Carbamate compounds and of making and using same
WO2010017545A3 (en) Triazole compounds that modulate hsp90 activity
IL221146A (en) 2,5-disubstituted pyridine derivatives, pharmaceutical compositions comprising the same and uses thereof in the preparation of medicaments for preventing or treating cancer
WO2012078593A3 (en) Lysophosphatidic acid receptor antagonists and their use in the treatment fibrosis
GEP20125469B (en) Inhibitors of akt activity
MX2009008084A (en) 5,6,7,8-tetrahydropteridine derivatives as hsp90 inhibitors.
WO2012050396A3 (en) Pharmaceutical composition including herbal medicine extract for preventing or treating liver cancer
WO2011049327A3 (en) A skin external composition comprising a salt and sugar as active ingredients for preventing and treating vaginosis and the use thereof
EP3279210A4 (en) Peptide having anticancer activity, and pharmaceutical composition and dietary supplement composition for preventing and treating cancer, both of which contain same as active ingredient
WO2013019093A3 (en) Novel aniline derivatives and use thereof
WO2011058245A8 (en) Novel mannopyranoside derivatives with anticancer activity
WO2013027988A3 (en) Recombinant adenovirus comprising trans-splicing ribozyme and cancer-treating gene, and use thereof
WO2009114658A3 (en) Androgen receptor inactivation contributes to antitumor efficacy of cyp17 inhibitors in prostate cancer
WO2011153458A3 (en) Compositions and methods for inhibition of or treatment of dengue virus infection
WO2009019708A3 (en) Pharmaceutical compositions and methods for the treatment of cancer

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08845515

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 08845515

Country of ref document: EP

Kind code of ref document: A2